Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3SZ9

Crystal structure of human ALDH2 modified with the beta-elimination product of Aldi-3; 1-(4-ethylbenzene)prop-2-en-1-one

Summary for 3SZ9
Entry DOI10.2210/pdb3sz9/pdb
Related3SZA 3SZB
DescriptorAldehyde dehydrogenase, mitochondrial, SODIUM ION, GUANIDINE, ... (6 entities in total)
Functional Keywordsaldh, aldi-3, inhibitor, rossmann fold, oxidoreductase, covalent adduct, mitochondria, oxidoreductase-oxidoreductase inhibitor complex, oxidoreductase/oxidoreductase inhibitor
Biological sourceHomo sapiens (human)
Cellular locationMitochondrion matrix: P05091
Total number of polymer chains8
Total formula weight439845.46
Authors
Perez-Miller, S.,Hurley, T.D. (deposition date: 2011-07-18, release date: 2011-11-02, Last modification date: 2024-11-06)
Primary citationKhanna, M.,Chen, C.H.,Kimble-Hill, A.,Parajuli, B.,Perez-Miller, S.,Baskaran, S.,Kim, J.,Dria, K.,Vasiliou, V.,Mochly-Rosen, D.,Hurley, T.D.
Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases.
J.Biol.Chem., 286:43486-43494, 2011
Cited by
PubMed Abstract: Human aldehyde dehydrogenases (ALDHs) comprise a family of 17 homologous enzymes that metabolize different biogenic and exogenic aldehydes. To date, there are relatively few general ALDH inhibitors that can be used to probe the contribution of this class of enzymes to particular metabolic pathways. Here, we report the discovery of a general class of ALDH inhibitors with a common mechanism of action. The combined data from kinetic studies, mass spectrometric measurements, and crystallographic analyses demonstrate that these inhibitors undergo an enzyme-mediated β-elimination reaction generating a vinyl ketone intermediate that covalently modifies the active site cysteine residue present in these enzymes. The studies described here can provide the basis for rational approach to design ALDH isoenzyme-specific inhibitors as research tools and perhaps as drugs, to address diseases such as cancer where increased ALDH activity is associated with a cellular phenotype.
PubMed: 22021038
DOI: 10.1074/jbc.M111.293597
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

230744

PDB entries from 2025-01-29

PDB statisticsPDBj update infoContact PDBjnumon